iifl-logo-icon 1

Biogen Pharmachem Industries Ltd Cash Flow Statement

1.04
(2.97%)
Feb 19, 2025|11:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Biogen Pharma FINANCIALS

Y/e 31 Mar( In .Cr)Mar-2016Mar-2015Mar-2014Mar-2013

Profit before tax

0

0

0

0

Depreciation

0

0

0

0

Tax paid

0

0

0

0

Working capital

-4.69

5.77

1.2

-22.35

Other operating items

Operating

-4.69

5.77

1.2

-22.35

Capital expenditure

0

0

0

0

Free cash flow

-4.69

5.77

1.2

-22.35

Equity raised

-8.57

-8.41

-8.15

-7.88

Investing

-17.09

-17.08

8.99

46.12

Financing

16.21

67.21

57.21

4

Dividends paid

0

0

0

0

Net in cash

-14.14

47.49

59.25

19.89

Biogen Pharma : related Articles

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.